Study uses spatial transcriptomics to map intratumoral heterogeneity and microenvironmental dynamics in triple-negative ...

BIRMINGHAM, Ala. – Pathways to new treatments for heart failure take time — as long as four decades for two now accepted therapies. So, new attempts ...

Phase 3 trial results published in European Journal of Heart Failure identify key target population for Mesoblast allogeneic cell therapyNEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- (Nasdaq:MESO; ...

A Swedish startup wants to democratize stem cell treatments, but the finances of the unproven therapies raise ethical ...